Tvardi Therapeutics Q3 2025 Earnings: Loss Narrows, Beats Estimates – News and Statistics

The Sugar Land, Texas-based company said it had a per-share loss of 59 cents. The results exceeded Wall Street expectations, with the average estimate …

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.